Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 AUD | 0.00% | +4.27% | -8.50% |
03-19 | Morgan Stanley Upgrades Baby Bunting to Overweight from Equalweight; Price Target is AU$2.20 | MT |
02-20 | Baby Bunting Shares Drop 12% as H1 FY24 Revenue Declines 2.5%, Profit Slips | MT |
Sales 2024 * | 510M 333M 26.68B | Sales 2025 * | 548M 358M 28.66B | Capitalization | 246M 161M 12.86B |
---|---|---|---|---|---|
Net income 2024 * | 9M 5.88M 471M | Net income 2025 * | 16M 10.45M 837M | EV / Sales 2024 * | 0.82 x |
Net Debt 2024 * | 172M 112M 8.98B | Net Debt 2025 * | 173M 113M 9.04B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
13.3
x | Employees | - |
Yield 2024 * |
3.03% | Yield 2025 * |
4.83% | Free-Float | 95.1% |
Latest transcript on Baby Bunting Group Limited
1 week | +4.27% | ||
Current month | -12.86% | ||
1 month | -11.17% | ||
3 months | +10.57% | ||
6 months | +7.65% | ||
Current year | -8.50% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Teperson
CEO | Chief Executive Officer | - | 01/10/23 |
Darin Hoekman
DFI | Director of Finance/CFO | - | 31/12/13 |
Matt Rodda
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Roche
BRD | Director/Board Member | - | 31/08/21 |
Gary Levin
BRD | Director/Board Member | - | 24/08/14 |
Gary Kent
BRD | Director/Board Member | - | 11/12/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.83 | 0.00% | 71,766 |
24/04/24 | 1.83 | +0.83% | 123,258 |
23/04/24 | 1.815 | +1.40% | 48,766 |
22/04/24 | 1.79 | +1.99% | 33,909 |
19/04/24 | 1.755 | -0.85% | 88,102 |
Delayed Quote Australian S.E., April 26, 2024 at 07:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.50% | 160M | |
+27.38% | 29.56B | |
+4.90% | 5.71B | |
-11.42% | 4.42B | |
+14.25% | 4.17B | |
+4.23% | 1.85B | |
-4.59% | 1.77B | |
-13.78% | 1.26B | |
-17.17% | 1.15B | |
-2.08% | 613M |
- Stock Market
- Equities
- BBN Stock